$SQNS

MultiTech Selects Sequans to Power Next-Generation Embedded Cellular Modem Platforms

MultiTech has partnered with Sequans to develop future embedded cellular modem platforms, initially leveraging Sequans' Calliope 2 LTE Cat 1bis platform and expanding to 5G. This collaboration aims to deliver secure, carrier-approved solutions, accelerating time-to-market and simplifying IoT integration for various critical verticals. Both companies plan to showcase their partnership at CES 2026.

Original reporting
TMX Newsfile · NULL
Published Jan 5, 2026, 1:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 5, 2026, 2:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MultiTech Selects Sequans to Power Next-Generation Embedded Cellular Modem Platforms — source image
Decision brief

The 30-second read

$SQNSBullishMed
01

Why it matters

This strategic move positions Sequans favorably in the growing IoT connectivity market, potentially leading to increased revenues and market share.

02

Market read

The partnership is highly relevant within the IoT and wireless communication sectors, with potential ripple effects across related industries.

03

What to watch

Market competition from larger IoT chipmakers and potential regulatory hurdles in different regions could impact growth prospects.

Timing: Immediate to short-term (next 1-3 months)

Background

MultiTech's collaboration with Sequans aims to accelerate the deployment of secure, carrier-approved embedded cellular modems, leveraging Sequans' Calliope 2 LTE Cat 1bis platform and expanding into 5G.

Company-level read

Ticker impact

$SQNSBullishHigh confidence
Context

High relevance due to positive sentiment and strategic partnership in IoT connectivity.

Expected impact

Moderate upward movement expected over the next 3-6 months, contingent on successful product deployment and market acceptance.

Evidence & confidence

The news indicates a strategic partnership with clear technological advancements and market expansion plans, which are likely to positively influence Sequans' stock performance.

Market effects

Positive impact on the IoT and wireless communications sectors, potentially benefiting companies involved in IoT hardware and connectivity solutions.

Primarily affects North American and European markets where the companies operate and have significant customer bases.

Moderate; reflects growing global demand for IoT connectivity solutions but limited immediate impact on broader global markets.

Counterpoint

The partnership's success is not guaranteed; delays or technical challenges could dampen stock performance.

Key entities

  • MultiTech

    A provider of IoT hardware and solutions.

  • Sequans

    A wireless semiconductor company specializing in cellular connectivity solutions.

Related articles

$SQNSMedAI 8/10

Sequans (SQNS) Q2 2026 Earnings Call Transcript

Sequans Communications S.A. (SQNS) reported Q2 2026 revenue of $7.5 million, up 23.2% quarter over quarter but down 8.4% year over year. Net loss was $9.8 million ($0.65 per diluted ADS). Cash rose to $21.0 million, with 314 Bitcoin valued at about $18.4 million. Q3 revenue guidance was $8.5 million to $10 million.

$SQNSMed

SEQUANS COMMUNICATIONS (SQNS): Financial results for Q2 2026

SEQUANS COMMUNICATIONS (SQNS) furnished an SEC Form 6-K — earnings release. NEWS Sequans Communications Unaudited Second Quarter 2026 Preliminary Financial Results PARIS - August 4, 2026 - Sequans Communications S.A. (NYSE: SQNS) (“Sequans” or the “Company”), a leading provider of 5G/4G cellular IoT semiconductor solutions, today announced preliminary un

$MSTRMed

Bitcoin treasury companies unwind holdings as the DAT model comes under pressure

Bitcoin treasury companies are selling bitcoin and restructuring as share prices fall and debt obligations rise. Strategy (MSTR) has sold about 3,620 BTC and authorized more. Satsuma (SATS) approved liquidation of 668 BTC. Smarter Web (SWC) sold 178 BTC, Sequans (SQNS) sold 1,025 BTC, and Nakamoto (NAKA) sold about 284 BTC. Miners MARA and Bitdeer also reduced holdings, citing AI pivots.

$SQNSMedAI 9/10

Sequans (SQNS) Completes Bitcoin Unwind, Exits Digital Asset Strategy After Less Than a Year

Sequans Communications (NYSE: SQNS) said it has fully redeemed its remaining convertible debt, funded by selling part of its Bitcoin holdings. After retiring all convertible notes issued in July 2025, it holds about 658 BTC, “fully unencumbered,” and plans to monetize remaining BTC over time. The company began its Bitcoin treasury in June 2025, later sold more than 80% of peak holdings.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.